IL33 and colitis: Moreover, Gurtner’s experiments using a DSS-induced colitis model demonstrated that IL-33 and IFN-γ synergistically promote an increase in the A-Eos subset (with antimicrobial and cytotoxic properties (Figure 2)) in colonic eosinophils, hence minimizing colitis aggravation [76].